🔗 Permalink

Inventor profile of:

Pascal Druzgala

City:

Santa Rosa, California

Country:

United States

Published Applications:

Last publication date:

2026-04-02

Top Assignees for applications by Pascal Druzgala

The entities that hold a legal rights for patent applications filed by inventor Druzgala Pascal:

ARYX THERAPEUTICS, INC. 13 Fremont, CA United States
ARYx Therapeutics 10 Fremont, CA United States
Xyra LLC 5 Santa Rosa, CA United States
ARYX THERAPEUTICS 5 Santa Clara, CA United States
Aryx Therapeutics, Inc. 3 Santa Clara, CA United States
Altos Therapeutics, LLC 2 Los Altos, CA United States
Armetheon, Inc. 1 Menlo Park, CA United States
Aryx Therapeutics, Inc. 1 Freemont, CA United States
Xyra, LLC 1 Los Altos, CA United States
ARYx Therapeutics, Inc. 1 Fermont, CA United States

Recent patent applications by Druzgala Pascal

Pascal Druzgala from Santa Rosa, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-02

US20260091235A1

Human necessities

Methods for Reducing the Risk of Heart Failure or Strokes by Pharmacotherapy to Reduce Atrial Fibrillations

#2 | 2025-09-11

US20250281448A1

Human necessities

Cardioversion Methods Using Budiodarone

#3 | 2025-01-09

US20250009708A1

Human necessities

Cardioversion methods using budiodarone

#4 | 2024-07-18

US20240238596A1

Human necessities

Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations

#5 | 2024-02-01

US20240033531A1

Human necessities

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

#6 | 2023-11-23

US20230372284A1

Human necessities

METHODS FOR TREATING ATRIAL FIBRILLATIONS

#7 | 2023-11-09

US20230355990A1

Human necessities

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

#8 | 2023-07-27

US20230233863A1

Human necessities

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

#9 | 2023-07-13

US20230218907A1

Human necessities

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

#10 | 2014-11-27

US20140350005A1

Chemistry; metallurgy

Dantagonists, methods of synthesis and methods of use

#11 | 2013-02-14

US20130040987A1

Chemistry; metallurgy

Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

#12 | 2012-07-12

US20120178738A1

Chemistry; metallurgy

DIBENZO [B,F] [1,4]OXAZAPINE COMPOUNDS

#13 | 2012-01-12

US20120010228A1

Chemistry; metallurgy

Dantagonists, methods of synthesis and methods of use

#14 | 2010-07-22

US20100184815A1

Chemistry; metallurgy

AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA

#15 | 2009-03-26

US20090082430A1

Chemistry; metallurgy

Halogenated ester derivatives of coumarins for the treatment of coagulation disorders

#16 | 2008-10-16

US20080255088A1

Chemistry; metallurgy

Dibenzo[b,f][1,4]oxazapine compounds

#17 | 2008-09-11

US20080221204A1

Human necessities

Materials and Methods for Treating Coagulation Disorders

#18 | 2008-06-05

US20080132561A1

Chemistry; metallurgy

Materials and Methods for Treating Hypercholesterolemia

#19 | 2008-05-15

US20080114059A1

Chemistry; metallurgy

Novel Compounds For Treatment of Cardiac Arrhythmia and Methods of Use

#20 | 2008-04-10

US20080085921A1

Chemistry; metallurgy

Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

#21 | 2008-01-31

US20080027132A1

Chemistry; metallurgy

Haloalkyl ester derivatives of coumarin for the treatment of coagulation disorders

#22 | 2007-09-04

US10643699

Materials and methods for the treatment of hypertension and angina

#23 | 2007-08-23

US20070197580A1

Chemistry; metallurgy

5-HT3 receptor antagonists and methods of use

#24 | 2007-06-07

US20070129429A1

Human necessities

Materials And Methods For Treating Coagulation Disorders

#25 | 2007-03-15

US20070060640A1

Chemistry; metallurgy

Antiarrhythmic precursor compounds, methods of synthesis and methods of use

#26 | 2006-12-21

US20060287388A1

Chemistry; metallurgy

Materials and methods for treating coagulation disorders

#27 | 2006-12-07

US20060276535A1

Chemistry; metallurgy

Compounds for treatment of cardiac arrhythmia and methods of use

#28 | 2006-12-05

US10822129

Materials and methods for treating coagulation disorders

#29 | 2006-10-24

US10857108

5-HT3 receptor antagonists and methods of use

#30 | 2006-08-17

US20060183805A1

Chemistry; metallurgy

Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof

#31 | 2006-06-01

US20060116418A1

Chemistry; metallurgy

Materials and methods for treating hypercholesterolemia

#32 | 2006-05-09

US10763904

Ultrashort acting hypnotic barbiturates

#33 | 2006-03-02

US20060047000A1

Chemistry; metallurgy

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

#34 | 2006-02-23

US20060040987A1

Chemistry; metallurgy

Ultrashort-acting opioids for transdermal application

#35 | 2006-02-21

US10771483

Ultrashort-acting opioids for transdermal applications

#36 | 2005-11-03

US20050245603A1

Chemistry; metallurgy

Materials and methods for treating coagulation disorders

#37 | 2005-10-13

US20050228045A1

Chemistry; metallurgy

Compounds for treatment of cardiac arrhythmia and methods of use

#38 | 2005-10-04

US10624659

Materials and methods for treating hypercholesterolemia

#39 | 2005-09-08

US20050197363A1

Chemistry; metallurgy

Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

#40 | 2005-08-11

US20050176805A1

Physics

Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use

#41 | 2005-07-14

US20050154216A1

Chemistry; metallurgy

Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use

#42 | 2005-04-07

US20050075379A1

Chemistry; metallurgy

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

#43 | 2005-03-22

US10799546

Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use

#44 | 2005-03-10

US20050054676A1

Chemistry; metallurgy

Materials and methods for the treatment of depression

#45 | 2005-03-08

US10132750

Materials and methods for treating coagulation disorders

#46 | 2005-02-17

US20050037997A9

Chemistry; metallurgy

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

InventorID:

91849 ⎘